Skip to content

ASTERION RESEARCH & DEVELOPMENT: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ASTERION RESEARCH & DEVELOPMENT

BE 0682.704.608
NACE 72.101, Research and development on biotechnology
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€621,245
2024 · €37,163-€658,407
Equity
€1.6m
2024 · -€16,161+€1.7m
Cash
€0
2024 · €39-€39
Balance sheet total
€2.3m
2024 · €571,425+€1.7m

Largest movements

2024 to 2025
Assets
  • Financial fixed assets +€2.0m

    up €2.0m (+658.1%), from €301,109 to €2.3m

  • Receivables after one year -€151,481

    down €151,481 (-100.0%), from €151,481 to €0

  • Receivables within one year -€89,868

    down €89,868 (-85.2%), from €105,480 to €15,612

    of which Trade receivables: -€60,292

Equity and liabilities
  • Revaluation surpluses +€2.3m

    new in 2025: €2.3m

  • Profit (loss) carried forward -€621,245

    down €621,245 (-1789.8%), from -€34,711 to -€655,956

  • Tax, wage and social debts -€74,365

    down €74,365 (-100.0%), from €74,365 to €0

  • Debts after one year +€66,741

    up €66,741 (+20.2%), from €330,750 to €397,492

  • Other debts +€56,891

    up €56,891 (+38.1%), from €149,447 to €206,338

Income statement
  • Write-downs +€500,035

    new in 2025: €500,035

  • Gross operating margin -€211,936

    down €211,936, from €119,958 to -€91,977

  • Other operating charges -€47,637

    down €47,637 (-92.5%), from €51,498 to €3,861

  • Financial charges -€4,315

    down €4,315 (-15.5%), from €27,883 to €23,567

  • Financial income +€1,611

    up €1,611 (+104.0%), from €1,548 to €3,159

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €37,163
Gross operating margin -€211,936
Depreciation +€0
Write-downs -€500,035
Other operating charges +€47,637
Financial income +€1,611
Financial charges +€4,315
Result 2025 -€621,245

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€366,636
Investment -€2.0m
Financing +€2.3m
Cash 2024 €39
Net result for the year -€621,245
Depreciation +€4,963
Receivables after one year +€151,481
Receivables within one year +€89,868
Trade debts +€25,771
Tax, wage and social debts -€74,365
Other debts +€56,891
Investment in fixed assets (net) -€2.0m
Debts after one year +€66,741
Short-term financial debts -€144
Contributions, distributions and other +€2.3m
Cash 2025 €0
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €571,425 €2,306,761 +€1.7m +303.7%
Fixed assets 21/28 €314,426 €2,291,149 +€2.0m +628.7%
Intangible fixed assets 21 €6,901 €3,446 -€3,455 -50.1%
Tangible fixed assets 22/27 €6,416 €4,907 -€1,509 -23.5%
Furniture and vehicles 24 €6,416 €4,907 -€1,509 -23.5%
Financial fixed assets 28 €301,109 €2,282,796 +€2.0m +658.1%
Current assets 29/58 €256,999 €15,612 -€241,387 -93.9%
Amounts receivable after more than one year 29 €151,481 €0 -€151,481 -100.0%
Other amounts receivable 291 €151,481 €0 -€151,481 -100.0%
Amounts receivable within one year 40/41 €105,480 €15,612 -€89,868 -85.2%
Trade receivables 40 €65,525 €5,233 -€60,292 -92.0%
Other amounts receivable 41 €39,955 €10,379 -€29,576 -74.0%
Cash at bank and in hand 54/58 €39 €0 -€39 -100.0%
Total equity and liabilities 10/49 €571,425 €2,306,761 +€1.7m +303.7%
Equity 10/15 -€16,161 €1,644,281 +€1.7m
Contributions 10/11 €18,550 €18,550 = 0.0%
Revaluation surpluses 12 - €2,281,687 +€2.3m
Profit (loss) carried forward 14 -€34,711 -€655,956 -€621,245 -1789.8%
Amounts payable 17/49 €587,586 €662,480 +€74,895 +12.7%
Amounts payable after more than one year 17 €330,750 €397,492 +€66,741 +20.2%
Financial debts 170/4 €330,750 €397,492 +€66,741 +20.2%
Amounts payable within one year 42/48 €256,835 €264,988 +€8,153 +3.2%
Financial debts 43 €144 €0 -€144 -100.0%
Credit institutions 430/8 €144 €0 -€144 -100.0%
Trade debts 44 €32,879 €58,650 +€25,771 +78.4%
Suppliers 440/4 €32,879 €58,650 +€25,771 +78.4%
Taxes, remuneration and social security 45 €74,365 €0 -€74,365 -100.0%
Taxes 450/3 €74,365 €0 -€74,365 -100.0%
Other amounts payable 47/48 €149,447 €206,338 +€56,891 +38.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,963 €4,963 -€0 0.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €500,035 +€500,035
Other operating charges 640/8 €51,498 €3,861 -€47,637 -92.5%
Gross operating margin 9900 €119,958 -€91,977 -€211,936
Operating profit (loss) 9901 €63,497 -€600,837 -€664,334
Financial income 75/76B €1,548 €3,159 +€1,611 +104.0%
Recurring financial income 75 €1,548 €3,159 +€1,611 +104.0%
Financial charges 65/66B €27,883 €23,567 -€4,315 -15.5%
Recurring financial charges 65 €27,883 €23,567 -€4,315 -15.5%
Profit (loss) for the period before taxes 9903 €37,163 -€621,245 -€658,407
Profit (loss) for the period 9904 €37,163 -€621,245 -€658,407
Profit (loss) for the period to be appropriated 9905 €37,163 -€621,245 -€658,407

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.